Clinical Trials Browser

Phase 2/3 × green tea extract polyphenone E × Clear all

NCT02029352 2016-05-18

Topical Green Tea Ointment in Treatment of Superficial Skin Cancer

Phase 2/3 Completed

Carcinoma, Basal Cell